Multicomponent Exercise Program to Improve the Immediate Sequelae of COVID-19: A Prospective Study with a Brief Report of 2-Year Follow-Up
- Martínez Rolando, Lidia 11223
- Villafañe, Jorge Hugo 4
- Cercadillo García, Soledad 123
- Sanz Argüello, Ana 123
- Villanueva Rosa, Marta 123
- Sánchez Romero, Eleuterio A. 1122
-
1
Universidad Europea de Madrid
info
-
2
Universidad Europea de Canarias
info
-
3
Hospital de Móstoles
info
- 4 IRCCS Fondazione Don Carlo Gnocchi, 20141 Milan, Italy
ISSN: 1660-4601
Año de publicación: 2022
Volumen: 19
Número: 19
Páginas: 12396
Tipo: Artículo
Otras publicaciones en: International Journal of Environmental Research and Public Health
Resumen
COVID-19 placed teams of professionals in a hostile and unfamiliar environment where the lack of knowledge of its pathology led to the adaptation of programs used so far for other conditions to try to address the immediate sequelae of COVID-19 infection. That is why the aim of this study was to assess the effects of a multicomponent exercise program (MEP) in improving cardio-respiratory performance, health status, disability due to dyspnea, aerobic capacity and endurance, and the immediate sequelae of COVID-19. Thirty-nine patients referred from different hospital services were included in this study. An intervention of seven weeks with sessions twice a week was carried out, where patients underwent intervallic training sessions followed by strengthening exercises and individualized respiratory physiotherapy exercises. The results of this study show a significant improvement in cardio-respiratory performance, health status, disability due to dyspnea, and aerobic capacity and endurance after intervention; and an increase in health status and reduction in disability due to dyspnea at the 2-year follow-up. In addition, none of the patients had any adverse effects either pre-post treatment or at the 2-year follow-up. Individualized and monitored MEP in survivors of COVID-19 showed positive effects in a pre-post evaluation and the 2-year follow up, improving the immediate sequelae of post-COVID-19 patients. This highlights the importance of the professional background of the rehabilitation teams in adapting to an unknown clinical environment.
Información de financiación
The APC was funded by the European University of Madrid C/Tajo s/n, 28670 Villaviciosa de Odón, Madrid, Spain. Award for Best Research Project in post-COVID-19 sequelae awarded by the Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid (Spain), December 2021.Financiadores
Referencias bibliográficas
- 1. Barker-Davies, R.M.; O’Sullivan, O.; Senaratne, K.P.P.; Baker, P.; Cranley, M.; Dharm-Datta, S.; Ellis, H.; Goodall, D.; Gough, M.; Lewis, S.; et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br. J. Sports Med. 2020, 54, 949–959.
- 2. Sánchez Romero, E.A.; Rolando, L.M.; Villafañe, J.H. Impact of Lockdown on Patients with Fibromyalgia. Electron. J. Gen. Med. 2022, 19, em366.
- 3. Long, B.; Carius, B.M.; Chavez, S.; Liang, S.Y.; Brady, W.J.; Koyfman, A.; Gottlieb, M. Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation. Am. J. Emerg. Med. 2022, 54, 46–57.
- 4. Reviriego, G.B.; Pascual, B.P.; Ruiz, A.R.; Sánchez Romero, E.A.; Corbelini, C.; Villafañe, J.H. Spanish Experience of Pulmonary Rehabilitation Efficacy for Patients Affected by the Novel SARS-CoV-2 (COVID-19): A Case Report. Top. Geriatr. Rehabil. 2020, 36, 212–214.
- 5. Sánchez Romero, E.A.; Pérez, J.L.A.; Suárez, I.V.; Corbellini, C.; Villafañe, J.H. Spanish experience on the efficacy of airways clearance techniques in SARS-CoV-2 (COVID-19) at intensive care unit: An editorial and case report. SAGE Open Med. Case Rep. 2022, 10, 2050313X221112507.
- 6. Fiore, E.; Corbellini, C.; Acucella, L.; Gargano, S.; Sánchez Romero, E.A.; Cotella, D.; Villafañe, J.H. Musculoskeletal pain related to COVID-19 survivors after hospitalization: A short review (Dolor musculoesquelético en supervivientes del COVID-19 tras la hospitalización: Una breve revision). Retos 2022, 44, 789–795.
- 7. Corbellini, C.; Villafane, J.; Gugliotta, E.; Tavella, S.; Zampese, S.; Pessina, P.; Monti, R.; Carnuccio, C.; Sánchez Romero, E.A.; Meroni, R. Late Breaking Abstract–Pulmonary rehabilitation in post–COVID subjects with moderate lung restriction, a case series. Eur. Respir. J. 2021, 58 (Suppl. 65), PA2003.
- 8. Talman, S.; Boonman-de Winter LJ, M.; De Mol, M.; Hoefman, E.; Van Etten, R.W.; De Backer, I.C. Pulmonary function and health-related quality of life after COVID-19 pneumonia. Respir. Med. 2021, 176, 106272.
- 9. Peeling, R.W.; Heymann, D.L.; Teo, Y.Y.; Garcia, P.J. Diagnostics for COVID-19: Moving from pandemic response to control. Lancet 2022, 399, 757–768.
- 10. Chilamakuri, R.; Agarwal, S. COVID-19: Characteristics and Therapeutics. Cells 2021, 10, 206.
- 11. Goodwin, V.A.; Allan, L.; Bethel, A.; Cowley, A.; Cross, J.L.; Day, J.; Drummond, A.; Hall, A.J.; Howard, M.; Morley, N.; et al. Rehabilitation to enable recovery from COVID-19: A rapid systematic review. Physiotherapy 2021, 111, 4–22.
- 12. de Sire, A.; Andrenelli, E.; Negrini, F.; Patrini, M.; Lazzarini, S.G.; Ceravolo, M.G.; The International Multiprofessional Steering Committee of Cochrane Rehabilitation REH-COVER Action. Rehabilitation and COVID-19: The Cochrane Rehabilitation 2020 rapid living systematic review. Eur. J. Phys. Rehabil. Med. 2020, 56, 839–845. [CrossRef] [PubMed]
- 13. Corbellini, C.; Rossino, E.; Massaccesi, R.; Battaglino, A.; Pedersini, P.; Sánchez Romero, E.A.; Villafañe, J.H. Improvements in Perimeter Thoracic Mobility on Patients with COPD after Pulmonary Rehabilitation: A Case Series. Electron. J. Gen. Med. 2022, 19, em361. [CrossRef]
- 14. Neder, J.A.; Marillier, M.; Bernard, A.-C.; James, M.D.; Milne, K.M.; O’Donnell, D.E. The Integrative Physiology of Exercise Training in Patients with COPD. COPD: J. Chronic Obstr. Pulm. Dis. 2019, 16, 182–195. [CrossRef]
- 15. Schulté, B.; Nieborak, L.; Leclercq, F.; Villafañe, J.H.; Sánchez Romero, E.A.; Corbellini, C. The Comparison of High-Intensity Interval Training Versus Moderate-Intensity Continuous Training after Coronary Artery Bypass Graft: A Systematic Review of Recent Studies. J. Cardiovasc. Dev. Dis. 2022, 9, 328.
- 16. Jimeno-Almazán, A.; Pallarés, J.; Buendía-Romero, A.; Martínez-Cava, A.; Franco-López, F.; Martínez, B.S.-A.; Bernal-Morel, E.; Courel-Ibáñez, J. Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int. J. Environ. Res. Public Health 2021, 18, 5329.
- 17. Udina, C.; Ars, J.; Morandi, A.; Vilaró, J.; Cáceres, C.; Inzitari, M. Rehabilitation in adult post-COVID-19 patients in post-acute care with Therapeutic Exercise. J. Frailty Aging 2021, 10, 297–300.
- 18. Cuenca-Zaldivar, J.N.; Acevedo, M.; Fernández-Carnero, J.; Sánchez-Romero, E.A.; Villafañe, J.H.; Carballar, C.B. Effects of a Multicomponent Exercise Program on Improving Frailty in Post-COVID-19 Older Adults after Intensive Care Units: A Single-Group Retrospective Cohort Study. Biology 2022, 11, 1084.
- 19. Global Burden of Disease 2020 Health Financing Collaborator Network. Tracking development assistance for health and for COVID-19: A review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050. Lancet 2021, 398, 1317–1343.
- 20. Curci, C.; Pisano, F.; Bonacci, E.; Camozzi, D.M.; Ceravolo, C.; Bergonzi, R.; De Franceschi, S.; Moro, P.; Guarnieri, R.; Ferrillo, M. Early rehabilitation in post-acute COVID-19 patients: Data from an Italian COVID-19 Rehabilitation Unit and proposal of a treatment protocol. Eur. J. Phys. Rehabilitation Med. 2020, 56, 633–641.
- 21. Sánchez Romero, E.A.; Carnero, J.F.; Pérez, J.L.A.; Rolando, L.M.; Villafañe, J.H. Addressing post-COVID-19 musculoskeletal symptoms through telemedicine: A study protocol. F1000Research 2022, 11, 898.
- 22. Yasui, H.; Inui, N.; Karayama, M.; Mori, K.; Hozumi, H.; Suzuki, Y.; Furuhashi, K.; Enomoto, N.; Fujisawa, T.; Nakamura, Y.; et al. Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease. Respir. Med. 2019, 146, 76–80. [CrossRef] [PubMed]
- 23. Poudel, A.N.; Zhu, S.; Cooper, N.; Roderick, P.; Alwan, N.; Tarrant, C.; Ziauddeen, N.; Yao, G.L. Impact of COVID-19 on health-related quality of life of patients: A structured review. PLoS ONE 2021, 16, e0259164. [CrossRef] [PubMed]
- 24. Daynes, E.; Gerlis, C.; Briggs-Price, S.; Jones, P.; Singh, S.J. COPD assessment test for the evaluation of COVID-19 symptoms. Thorax 2021, 76, 185–187. [CrossRef] [PubMed]
- 25. Zhou, Z.; Zhou, A.; Zhao, Y.; Chen, P. Evaluating the Clinical COPD Questionnaire: A systematic review. Respirology 2017, 22, 251–262. [CrossRef]
- 26. Kendrick, K.R.; Baxi, S.C.; Smith, R.M. Usefulness of the modified 0–10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J. Emerg. Nurs. 2000, 26, 216–222. [
- 27. Ferioli, M.; Prediletto, I.; Bensai, S.; Betti, S.; Daniele, F.; Scioscio, V.D.; Modolon, C.; Rimondi, M.R.; Nava, S.; Fasano, L. The role of 6MWT in COVID-19 follow up. Paper presented at: ERS 2021. The European Respiratory Society International Congress. Eur. Respir. J. 2021, 58, OA4046.
- 28. Simonelli, C.; Paneroni, M.; Vitacca, M.; Ambrosino, N. Measures of physical performance in COVID-19 patients: A mapping review. Pulmonology 2021, 27, 518–528.
- 29. Werkman, M.S.; Bongers, B.C.; Blatter, T.; Takken, T.; Wittink, H. Extended steep ramp test normative values for 19–24-year-old healthy active young adults. Eur. J. Appl. Physiol. 2020, 120, 107–115.
- 30. Weemaes, A.T.; Beelen, M.; Bongers, B.C.; Weijenberg, M.P.; Lenssen, A.F. Criterion Validity and Responsiveness of the Steep Ramp Test to Evaluate Aerobic Capacity in Survivors of Cancer Participating in a Supervised Exercise Rehabilitation Program. Arch. Phys. Med. Rehabil. 2021, 102, 2150–2156.
- 31. Daher, A.; Balfanz, P.; Cornelissen, C.; Müller, A.; Bergs, I.; Marx, N.; Müller-Wieland, D.; Hartmann, B.; Dreher, M.; Müller, T. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir. Med. 2020, 174, 106197.
- 32. Scavone, C.; Brusco, S.; Bertini, M.; Sportiello, L.; Rafaniello, C.; Zoccoli, A.; Berrino, L.; Racagni, G.; Rossi, F.; Capuano, A. Current pharmacological treatments for COVID-19: What’s next? Br. J. Pharmacol. 2020, 177, 4813–4824.